NextMed
NextMed, founded in 1996, specializes in patient-centered lithotripsy services for kidney stone treatment, utilizing AI technology to enhance treatment accuracy and outcomes.
Founders
NextMed was founded in 1996 by the sons of a urologist. The founding team's unique background in urology played a pivotal role in establishing a company focused on patient-centered lithotripsy services. Their expertise and familial connection to the medical field helped shape the company's initial mission and continue to guide its operations today.
Services
NextMed provides a variety of kidney stone treatments with a 99% success rate. The company offers in-office kidney stone treatment through its NextWave technology and an innovative service called URS+TM for ureteroscopy needs. URS+TM is designed to provide cost savings and flexibility in care settings. Additionally, NextMed utilizes a Stone Decision Engine to determine the best treatment options based on specific stone qualities, ensuring personalized and effective care for each patient.
Technology and Innovation
NextMed employs advanced technology to improve treatment processes and outcomes. The company's use of AI technology plays a crucial role in enhancing their data-driven approach to lithotripsy, facilitating continuous improvement in treatment protocols. The Stone Decision Engine is another technological innovation that assists in selecting the most appropriate treatment for kidney stones based on their specific characteristics.
Accreditations
NextMed operates under strict quality standards and is accredited by the Healthcare Facilities Accreditation Program (HFAP). This accreditation underscores the company's commitment to high-quality care. Their comprehensive lithotripsy program is certified by HFAP, reflecting their adherence to stringent clinical and operational criteria. This certification assures patients and physicians of NextMed's dedication to maintaining excellence in their services.
Headquarters and Reach
NextMed is headquartered at 6339 E Speedway Blvd., Suite 201, Tucson, AZ. Despite its single headquarters, the company has a broad reach, providing services to nearly 400 physicians nationwide. This extensive network indicates NextMed's significant impact on the field of urology and its role in improving kidney stone treatment accessibility across various regions.